Healthcare - Biotechnology - NASDAQ - US
$ 4.79
-11 %
$ 406 M
Market Cap
-1.95
P/E
Price Target
Average
321.71%
Revenue Forecast
Estimate
3.71%
EBIT
Estimate
19.10%
Net Income
Estimate
--2.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Verve Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for VERV of $20.2 , with forecasts ranging from a low of $13 to a high of $30 .
VERV Lowest Price Target
Wall Street Target
13 USD
171.40%
VERV Average Price Target
Wall Street Target
20.2 USD
321.71%
VERV Highest Price Target
Wall Street Target
30 USD
526.30%
REVENUE FORECAST
Revenue Forecast Chart VERV
EBIT FORECAST
EBIT Forecast Chart VERV
NET INCOME FORECAST
Net Income Chart VERV